- Home
- IMMP vs ALTI Comparison
IMMP vs ALTI Comparison
Compare IMMP & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- ALTI
- Stock Information
- Founded
- IMMP 1987
- ALTI 2020
- Country
- IMMP Australia
- ALTI United States
- Employees
- IMMP N/A
- ALTI N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- ALTI Investment Managers
- Sector
- IMMP Health Care
- ALTI Finance
- Exchange
- IMMP Nasdaq
- ALTI Nasdaq
- Market Cap
- IMMP 211.1M
- ALTI 302.7M
- IPO Year
- IMMP N/A
- ALTI N/A
- Fundamental
- Price
- IMMP $1.86
- ALTI $3.29
- Analyst Decision
- IMMP Buy
- ALTI
- Analyst Count
- IMMP 2
- ALTI 0
- Target Price
- IMMP $8.50
- ALTI N/A
- AVG Volume (30 Days)
- IMMP 648.0K
- ALTI 73.4K
- Earning Date
- IMMP 05-16-2025
- ALTI 05-12-2025
- Dividend Yield
- IMMP N/A
- ALTI N/A
- EPS Growth
- IMMP N/A
- ALTI N/A
- EPS
- IMMP N/A
- ALTI N/A
- Revenue
- IMMP $3,019,249.00
- ALTI $206,935,000.00
- Revenue This Year
- IMMP $11.25
- ALTI $24.86
- Revenue Next Year
- IMMP $10.22
- ALTI $10.74
- P/E Ratio
- IMMP N/A
- ALTI N/A
- Revenue Growth
- IMMP 24.11
- ALTI N/A
- 52 Week Low
- IMMP $1.32
- ALTI $2.33
- 52 Week High
- IMMP $3.34
- ALTI $5.45
- Technical
- Relative Strength Index (RSI)
- IMMP 53.43
- ALTI 54.28
- Support Level
- IMMP $1.44
- ALTI $3.18
- Resistance Level
- IMMP $2.71
- ALTI $3.50
- Average True Range (ATR)
- IMMP 0.17
- ALTI 0.18
- MACD
- IMMP 0.05
- ALTI -0.01
- Stochastic Oscillator
- IMMP 29.75
- ALTI 47.50
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About ALTI AlTi Global Inc.
AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.